For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Democratic deficit in health reforms
+Opinion
In print
Democratic deficit in health reforms
Wednesday 20 April 2022, 10:06 AM

The Pae Ora (Healthy Futures) Bill is set to tip the current balance [Image: Styf22 on iStock]
VIEWPOINT
The public was never asked whether it wanted the end of the degree of local control enjoyed by the DHBs, writes Ian Powell
Every piece of parliamentary legislation has a “purpose” clause describing the legal means or effect of the legislation. This serves to communicate it
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.